{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:26:40Z","timestamp":1793467600260,"version":"4.5.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["LSHM16058-SGF"],"award-info":[{"award-number":["LSHM16058-SGF"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> The glomerular endothelial glycocalyx is degraded during inflammation. The glycocalyx plays a pivotal role in endothelial function and is involved in many processes including binding of chemokines and cytokines, leukocyte trafficking, and preventing proteinuria. HS-based therapeutics are a promising novel class of anti-inflammatory drugs to restore a compromised endothelial glycocalyx under inflammatory conditions. Recently, we demonstrated that treatment with HS extracted from unstimulated glomerular endothelial glycocalyx (unstimulated HS<jats:sub>glx<\/jats:sub>) reduced albuminuria during anti-GBM induced glomerulonephritis. Since endothelial HS domains are distinct in unstimulated <jats:italic>versus<\/jats:italic> inflammatory conditions, we hypothesized that 1) unstimulated HS<jats:sub>glx<\/jats:sub>, 2) LPS-stimulated HS<jats:sub>glx<\/jats:sub>, 3) the HS-mimetic fucoidan and 4) the glycosaminoglycan preparation sulodexide, which is a mixture of low molecular weight heparin and dermatan sulfate, might have different beneficial effects in experimental glomerulonephritis.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The effect of unstimulated HS<jats:sub>glx<\/jats:sub>, LPS HS<jats:sub>glx<\/jats:sub>, Laminaria japonica fucoidan, or sulodexide on experimental glomerulonephritis was tested in LPS-induced glomerulonephritis in mice. Analyses included urinary albumin creatinine measurement, cytokine expression in plasma and renal cortex, and renal influx of immune cells determined by flow cytometry and immunofluorescence staining. Furthermore, the observed <jats:italic>in vivo<\/jats:italic> effects were evaluated in cultured glomerular endothelial cells and peripheral blood mononuclear cells by measuring cytokine and ICAM-1 expression levels. The ability of the compounds to inhibit heparanase activity was assessed in a heparanase activity assay.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Treatment of mice with LPS HS<jats:sub>glx<\/jats:sub> or sulodexide near-significantly attenuated LPS-induced proteinuria. All treatments reduced plasma MCP-1 levels, whereas only fucoidan reduced IL-6 and IL-10 plasma levels. Moreover, all treatments reversed cortical ICAM-1 mRNA expression and both fucoidan and sulodexide reversed cortical IL-6 and nephrin mRNA expression. Sulodexide decreased renal influx of CD45<jats:sup>+<\/jats:sup> immune cells whereas renal influx of macrophages and granulocytes remained unaltered for all treatments. Although all compounds inhibited HPSE activity, fucoidan and sulodexide were the most potent inhibitors. Notably, fucoidan and sulodexide decreased LPS-induced mRNA expression of ICAM-1 and IL-6 by cultured glomerular endothelial cells.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our data show a potentially protective effect of glycosaminoglycans and fucoidan in experimental glomerulonephritis. Future research should be aimed at the further identification of defined HS structures that have therapeutic potential in the treatment of glomerular diseases.<\/jats:p>","DOI":"10.3389\/fmolb.2023.1223972","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:19:59Z","timestamp":1688555999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis"],"prefix":"10.3389","volume":"10","author":[{"given":"Baranca","family":"Buijsers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Maciej-Hulme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinka Bakker-van","family":"Bebber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rustem","family":"Salmenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Parr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton J.","family":"Rabelink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Nijenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"van der Vlag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9316751","DOI":"10.1155\/2020\/9316751","article-title":"Fucoidan ameliorates oxidative stress, inflammation, DNA damage, and hepatorenal injuries in diabetic rats intoxicated with aflatoxin B(1)","volume":"2020","author":"Aleissa","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/ki.1993.315","article-title":"Expression of vascular cell adhesion molecule-1 in kidney allograft rejection","volume":"44","author":"Alpers","year":"1993","journal-title":"Kidney Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2006.12.009","article-title":"Sulodexide induces hepatocyte growth factor release in humans","volume":"558","author":"Borawski","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/ki.1994.169","article-title":"Leukocyte adhesion molecules and kidney diseases","volume":"45","author":"Brady","year":"1994","journal-title":"Kidney Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1007\/s00125-010-1910-x","article-title":"Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus","volume":"53","author":"Broekhuizen","year":"2010","journal-title":"Diabetologia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1098184","DOI":"10.3389\/fphar.2023.1098184","article-title":"Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy","volume":"14","author":"Buijsers","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"575047","DOI":"10.3389\/fimmu.2020.575047","article-title":"Increased plasma heparanase activity in COVID-19 patients","volume":"11","author":"Buijsers","year":"","journal-title":"Front. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"102969","DOI":"10.1016\/j.ebiom.2020.102969","article-title":"Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients","volume":"59","author":"Buijsers","year":"","journal-title":"EBioMedicine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1242\/jcs.00662","article-title":"Endothelial inflammation: The role of differential expression of N-deacetylase\/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate","volume":"116","author":"Carter","year":"2003","journal-title":"J. Cell Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MPA.0b013e3182a63b9d","article-title":"Protective effects of fucoidan, a P- and L-selectin inhibitor, in murine acute pancreatitis","volume":"43","author":"Carvalho","year":"2014","journal-title":"Pancreas"},{"key":"B11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.semnephrol.2010.03.003","article-title":"Macrophages and immunologic inflammation of the kidney","volume":"30","author":"Duffield","year":"2010","journal-title":"Semin. Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1369\/0022155417740881","article-title":"The role of heparan sulfate in inflammation, and the development of biomimetics as anti-inflammatory strategies","volume":"66","author":"Farrugia","year":"2018","journal-title":"J. Histochem Cytochem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ijbiomac.2017.07.031","article-title":"A fucoidan fraction purified from Chnoospora minima; a potential inhibitor of LPS-induced inflammatory responses","volume":"104","author":"Fernando","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1165\/rcmb.2002-0084OC","article-title":"Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue","volume":"28","author":"Frevert","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/ki.2011.58","article-title":"The glomerular endothelial cell coat is essential for glomerular filtration","volume":"79","author":"Frid\u00e9n","year":"2011","journal-title":"Kidney Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ajpath.2015.12.008","article-title":"Heparanase is essential for the development of acute experimental glomerulonephritis","volume":"186","author":"Garsen","year":"2016","journal-title":"Am. J. Pathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/ndt\/gft410","article-title":"The role of heparanase and the endothelial glycocalyx in the development of proteinuria","volume":"29","author":"Garsen","year":"2014","journal-title":"Nephrol. Dial. Transpl."},{"key":"B18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2337\/db11-1024","article-title":"Heparanase is essential for the development of diabetic nephropathy in mice","volume":"61","author":"Gil","year":"2012","journal-title":"Diabetes"},{"key":"B19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.matbio.2013.02.008","article-title":"Versatile role of heparanase in inflammation","volume":"32","author":"Goldberg","year":"2013","journal-title":"Matrix Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cmet.2014.09.016","article-title":"Reducing macrophage proteoglycan sulfation increases atherosclerosis and obesity through enhanced type I interferon signaling","volume":"20","author":"Gordts","year":"2014","journal-title":"Cell Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0119918","DOI":"10.1371\/journal.pone.0119918","article-title":"Endothelial nitric oxide synthase deficient mice are protected from lipopolysaccharide induced acute lung injury","volume":"10","author":"Gross","year":"2015","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"25714","DOI":"10.1074\/jbc.M109.032755","article-title":"Rapid purification and high sensitivity analysis of heparan sulfate from cells and tissues TOWARD GLYCOMICS PROFILING","volume":"284","author":"Guimond","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/ki.1994.4","article-title":"ICAM-1 directs migration and localization of interstitial leukocytes in experimental glomerulonephritis","volume":"45","author":"Hill","year":"1994","journal-title":"Kidney Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s13273-017-0045-2","article-title":"Fucoidan inhibits lipopolysaccharide-induced inflammatory responses in RAW 264.7 macrophages and zebrafish larvae","volume":"13","author":"Jeong","year":"2017","journal-title":"Mol. Cell. Toxicol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.5483\/bmbrep.2014.47.11.009","article-title":"Sulodexide inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy","volume":"47","author":"Jo","year":"2014","journal-title":"BMB Rep."},{"key":"B26","first-page":"1225","article-title":"N-acetyl cysteine blocks mesangial VCAM-1 and NF-kappa B expression in vivo","volume":"151","author":"Khachigian","year":"1997","journal-title":"Am. J. Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1369\/0022155412464972","article-title":"Heparan sulfate biosynthesis: Regulation and variability","volume":"60","author":"Kreuger","year":"2012","journal-title":"J. Histochem Cytochem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1527-3466.2006.00214.x","article-title":"Sulodexide: A renewed interest in this glycosaminoglycan","volume":"24","author":"Lauver","year":"2006","journal-title":"Cardiovasc Drug Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1478-811X-10-33","article-title":"Role of TLR4\/NADPH oxidase\/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells","volume":"10","author":"Lee","year":"2012","journal-title":"Cell Commun. Signal"},{"key":"B30","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1053\/j.ajkd.2011.06.020","article-title":"Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: A randomized controlled trial","volume":"58","author":"Lewis","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/joim.12061","article-title":"Pathophysiology of heparan sulphate: Many diseases, few drugs","volume":"273","author":"Lindahl","year":"2013","journal-title":"J. Intern Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/157016309789869001","article-title":"Therapeutic use of heparin beyond anticoagulation","volume":"6","author":"Ludwig","year":"2009","journal-title":"Curr. Drug Discov. Technol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1046\/j.1523-1755.2000.00308.x","article-title":"Nephrin in experimental glomerular disease","volume":"58","author":"Luimula","year":"2000","journal-title":"Kidney Int."},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1101\/2020.01.21.913954","article-title":"High sensitivity (zeptomole) detection of BODIPY heparan sulfate (HS) disaccharides by ion-paired RP-HPLC and LIF detection enables analysis of HS from mosquito midguts","author":"Maciej-Hulme","year":"2020"},{"key":"B35","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1042\/BST20170398","article-title":"The role of heparan sulfate in host macrophage infection by Leishmania species","volume":"46","author":"Maciej-Hulme","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"B36","doi-asserted-by":"publisher","first-page":"36185","DOI":"10.18632\/oncotarget.26324","article-title":"Inhibition of heparanase protects against chronic kidney dysfunction following ischemia\/reperfusion injury","volume":"9","author":"Masola","year":"2018","journal-title":"Oncotarget"},{"key":"B37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1479-5876-10-213","article-title":"A new mechanism of action of sulodexide in diabetic nephropathy: Inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition","volume":"10","author":"Masola","year":"2012","journal-title":"J. Transl. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"507151","DOI":"10.1155\/2015\/507151","article-title":"Anti-inflammatory effects of heparin and its derivatives: A systematic review","volume":"2015","author":"Mousavi","year":"2015","journal-title":"Adv. Pharmacol. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.1002\/jmv.27019","article-title":"Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19","volume":"93","author":"Muralidar","year":"2021","journal-title":"J. Med. Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1681\/ASN.2011040378","article-title":"Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy","volume":"23","author":"Packham","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/s0168-8227(97)00096-x","article-title":"Effect of glycosaminoglycans on urinary albumin excretion in insulin-dependent diabetic patients with micro- or macroalbuminuria","volume":"38","author":"Poplawska","year":"1997","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/md18050275","article-title":"Mechanisms of bioactivities of fucoidan from the Brown seaweed fucus vesiculosus L. Of the barents sea","volume":"18","author":"Pozharitskaya","year":"2020","journal-title":"Mar. Drugs"},{"key":"B43","doi-asserted-by":"publisher","first-page":"17832","DOI":"10.1074\/jbc.273.28.17832","article-title":"Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies","volume":"273","author":"Raats","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrneph.2017.6","article-title":"Heparanase: Roles in cell survival, extracellular matrix remodelling and the development of kidney disease","volume":"13","author":"Rabelink","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1046\/j.1365-2222.1998.00283.x","article-title":"Regulation of interleukin-8 binding and function by heparin and alpha2-macroglobulin","volume":"28","author":"Ramdin","year":"1998","journal-title":"Clin. Exp. Allergy"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1158\/1078-0432.CCR-10-2476","article-title":"SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase\/syndecan-1 axis","volume":"17","author":"Ritchie","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/ndt\/gfl801","article-title":"Heparan sulfate on activated glomerular endothelial cells and exogenous heparinoids influence the rolling and adhesion of leucocytes","volume":"22","author":"Rops","year":"","journal-title":"Nephrol. Dial. Transpl."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/ndt\/gfm194","article-title":"Expression of glomerular heparan sulphate domains in murine and human lupus nephritis","volume":"22","author":"Rops","year":"","journal-title":"Nephrol. Dial. Transpl."},{"key":"B49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/sj.ki.5002573","article-title":"Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking","volume":"73","author":"Rops","year":"2008","journal-title":"Kidney Int."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1111\/j.1523-1755.2004.66009.x","article-title":"Isolation and characterization of conditionally immortalized mouse glomerular endothelial cell lines","volume":"66","author":"Rops","year":"","journal-title":"Kidney Int."},{"key":"B51","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1523-1755.2004.00451.x","article-title":"Heparan sulfate proteoglycans in glomerular inflammation","volume":"65","author":"Rops","year":"","journal-title":"Kidney Int."},{"key":"B52","doi-asserted-by":"publisher","first-page":"9187","DOI":"10.1128\/JVI.75.19.9187-9200.2001","article-title":"Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages","volume":"75","author":"Saphire","year":"2001","journal-title":"J. Virol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/cei.13119","article-title":"The role of the immune system in kidney disease","volume":"192","author":"Tecklenborg","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/978-3-030-34521-1_26","article-title":"Heparanase in kidney disease","volume":"1221","author":"van der Vlag","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e0261722","DOI":"10.1371\/journal.pone.0261722","article-title":"Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis","volume":"16","author":"van Gemst","year":"2021","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/md17010032","article-title":"Fucoidan structure and activity in relation to anti-cancer mechanisms","volume":"17","author":"van Weelden","year":"2019","journal-title":"Mar. Drugs"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e0198013","DOI":"10.1371\/journal.pone.0198013","article-title":"Nephrin is necessary for podocyte recovery following injury in an adult mature glomerulus","volume":"13","author":"Verma","year":"2018","journal-title":"PLoS One"},{"key":"B58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/pl00000290","article-title":"Protective effect of low molecular weight heparin on experimental colitis: Role of neutrophil recruitment and TNF-alpha production","volume":"51","author":"Wan","year":"2002","journal-title":"Inflamm. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijbiomac.2010.05.010","article-title":"Structural studies on a novel fucogalactan sulfate extracted from the Brown seaweed Laminaria japonica","volume":"47","author":"Wang","year":"2010","journal-title":"Int. J. Biol. Macromol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/ni1233","article-title":"Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses","volume":"6","author":"Wang","year":"2005","journal-title":"Nat. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"790937","DOI":"10.3389\/fphar.2022.790937","article-title":"Fucoidan alleviates renal fibrosis in diabetic kidney disease via inhibition of NLRP3 inflammasome-mediated podocyte pyroptosis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.thromres.2006.10.026","article-title":"The anti-inflammatory effects of heparin and related compounds","volume":"122","author":"Young","year":"2008","journal-title":"Thromb. Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"00652","DOI":"10.1183\/23120541.00652-2021","article-title":"Heparan sulfate mimetic fucoidan restores the endothelial glycocalyx and protects against dysfunction induced by serum of COVID-19 patients in the intensive care unit","volume":"8","author":"Yuan","year":"2022","journal-title":"ERJ Open Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e54501","DOI":"10.1371\/journal.pone.0054501","article-title":"Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL\/6 mice with streptozotocin-induced type I diabetic nephropathy","volume":"8","author":"Yung","year":"2013","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.ijbiomac.2022.04.192","article-title":"Protective effects of fucoidan against kidney diseases: Pharmacological insights and future perspectives","volume":"209","author":"Zahan","year":"2022","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1223972\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:20:12Z","timestamp":1688556012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1223972\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":65,"alternative-id":["10.3389\/fmolb.2023.1223972"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1223972","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"article-number":"1223972"}}